GFACX
Price
$72.97
Change
-$0.51 (-0.69%)
Updated
Nov 18 closing price
Net Assets
329.73B
SLCGX
Price
$33.64
Change
-$0.30 (-0.88%)
Updated
Nov 18 closing price
Net Assets
40.36M
Interact to see
Advertisement

GFACX vs SLCGX

Header iconGFACX vs SLCGX Comparison
Open Charts GFACX vs SLCGXBanner chart's image
American Funds Growth Fund of Amer C
Price$72.97
Change-$0.51 (-0.69%)
VolumeN/A
Net Assets329.73B
Saratoga Large Capitalization Growth I
Price$33.64
Change-$0.30 (-0.88%)
VolumeN/A
Net Assets40.36M
GFACX vs SLCGX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. SLCGX commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and SLCGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 330B vs. SLCGX (40.4M). GFACX (0.00) and SLCGX (0.00) have matching dividends . GFACX was incepted earlier than SLCGX: GFACX (25 years) vs SLCGX (31 years). SLCGX (1.70) is less costly to investors than GFACX (1.36). SLCGX is a more actively managed with annual turnover of: 99.00 vs. GFACX (25.00). GFACX (250) and SLCGX (250) have matching initial minimum investment requirements. GFACX annual gain was more profitable for investors over the last year : 5.07 vs. SLCGX (-2.30). GFACX return over 5 years is better than : 24.08 vs. SLCGX (20.91).
GFACXSLCGXGFACX / SLCGX
Total Expense Ratio1.361.7080%
Annual Report Gross Expense Ratio1.361.7080%
Fund Existence25 years31 years-
Gain YTD14.44517.64382%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets330B40.4M816,832%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.07-2.30-220%
Returns for 3 years54.8653.23103%
Returns for 5 years24.0820.91115%
Returns for 10 years69.6614.86469%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBIOP6.900.21
+3.13%
Fortress Biotech
TLPH1.340.02
+1.52%
Talphera
JANX29.020.30
+1.04%
Janux Therapeutics
MBAV10.580.01
+0.09%
M3 Brigade Acquisition V Corp.
CDE14.38-0.08
-0.55%
Coeur Mining